CN Patent
CN105294801A — 6-乙基鹅去氧胆酸异构体的合成及其分离测定方法
Assigned to NANJING HAILING CHINESE MEDICINE PHARMACEUTICAL TECHNOLOGY RESEARCH Co Ltd · Expires 2016-02-03 · 10y expired
What this patent protects
本发明涉及一种奥贝胆酸异构体,即奥贝胆酸-ααβ体,奥贝胆酸-αβα体合成方法,以及采用反相液相色谱条件分奥贝胆酸异构体。采用本发明的技术方案可以得到HPLC纯度大于98%的奥贝胆酸-ααβ体,奥贝胆酸-αβα体,满足奥贝胆酸中异构体的质量控制。
USPTO Abstract
本发明涉及一种奥贝胆酸异构体,即奥贝胆酸-ααβ体,奥贝胆酸-αβα体合成方法,以及采用反相液相色谱条件分奥贝胆酸异构体。采用本发明的技术方案可以得到HPLC纯度大于98%的奥贝胆酸-ααβ体,奥贝胆酸-αβα体,满足奥贝胆酸中异构体的质量控制。
Drugs covered by this patent
- Ocaliva (OBETICHOLIC ACID) · Intercept Pharms Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.